News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,034 Results
Type
Article (26939)
Company Profile (139)
Press Release (230956)
Section
Business (65902)
Career Advice (1039)
Deals (10449)
Drug Delivery (56)
Drug Development (48761)
Employer Resources (69)
FDA (6173)
Job Trends (5735)
News (128028)
Policy (10459)
Tag
Academia (1510)
Alliances (19344)
Alzheimer's disease (669)
Antibody-drug conjugate (ADC) (63)
Approvals (6131)
Artificial intelligence (67)
Bankruptcy (76)
Best Places to Work (4995)
Biotechnology (118)
Breast cancer (87)
Cancer (896)
Career advice (849)
CAR-T (73)
Cell therapy (244)
Clinical research (37280)
Collaboration (207)
COVID-19 (1527)
Cystic fibrosis (53)
Data (669)
Diabetes (69)
Diagnostics (2809)
Drug pricing (48)
Earnings (24011)
Employer resources (63)
Events (37297)
Executive appointments (123)
FDA (6425)
Funding (164)
Gene editing (51)
Gene therapy (152)
GLP-1 (288)
Government (1607)
Healthcare (7145)
Infectious disease (1567)
Inflammatory bowel disease (59)
Interviews (219)
IPO (5269)
Job creations (949)
Job search strategy (690)
Layoffs (199)
Legal (1451)
Liver cancer (52)
Lung cancer (168)
Lymphoma (48)
Manufacturing (100)
Medical device (2921)
Medtech (2925)
Mergers & acquisitions (5247)
Metabolic disorders (175)
Neuroscience (837)
NextGen Class of 2024 (2291)
Non-profit (1348)
Northern California (655)
Obesity (93)
Opinion (128)
People (18058)
Phase I (13314)
Phase II (17050)
Phase III (11421)
Pipeline (260)
Postmarket research (983)
Preclinical (6050)
Press Release (57)
Radiopharmaceuticals (125)
Rare diseases (157)
Real estate (1631)
Regulatory (8102)
Research institute (1401)
Resumes & cover letters (201)
Southern California (595)
Startups (1504)
United States (5914)
Vaccines (293)
Weight loss (76)
Date
Today (105)
Last 7 days (498)
Last 30 days (1816)
Last 365 days (17372)
2024 (15614)
2023 (19371)
2022 (26880)
2021 (27375)
2020 (24144)
2019 (16801)
2018 (12641)
2017 (13216)
2016 (12106)
2015 (14415)
2014 (10031)
2013 (7962)
2012 (8300)
2011 (8208)
2010 (7034)
Location
Africa (323)
Asia (16277)
Australia (3354)
California (1498)
Canada (464)
China (144)
Colorado (50)
Connecticut (55)
Europe (36544)
Florida (167)
Illinois (103)
Indiana (51)
Maryland (274)
Massachusetts (1269)
Michigan (69)
Minnesota (91)
New Jersey (415)
New York (466)
North Carolina (294)
Northern California (655)
Ohio (61)
Pennsylvania (362)
South America (420)
Southern California (595)
Texas (211)
Washington State (244)
258,034 Results for "cell point".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Delivery
The Next Frontier: Industrializing Cell Therapy Manufacturing
Q&A: Development Scientist at AGC Biologics Sara Morlacchi analyzes the growth of the cell therapy industry and barriers for cost and accessibility.
April 29, 2024
·
7 min read
·
Sara Morlacchi, Cell Process Development Manager, AGC Biologics
Drug development
5 Sickle Cell Therapies to Watch Following Pfizer’s Oxbryta Exit
In the wake of Pfizer’s voluntary market withdrawal of the popular sickle cell disease therapy,
BioSpace
looks at five investigational drugs currently making their way through the pipeline.
October 21, 2024
·
4 min read
·
Kate Goodwin
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
Press Releases
Phio Announces Data Showcasing INTASYL’s Role in Helping Immune Cells Target and Kill Cancer Cells
INTASYL compounds also improve the functionality and outcomes of adoptive cell therapies such as NK, TIL and CAR-T
October 7, 2024
·
3 min read
Job trends
Cell Therapy Biotechs Hunt for Autoimmune Expertise in Pivot From Oncology
In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right expertise is in place to tackle the new disease area.
November 6, 2024
·
6 min read
·
Annalee Armstrong
Cell and gene therapy
Cell and Gene Therapy Investment Ticks Up After Hard Few Years
Tim Hunt, CEO of the Alliance for Regenerative Medicine, said Monday at the 2024 Cell & Gene Meeting on the Mesa that investments reached $10.9 billion in the first half of this year—outpacing 2019’s $9.8 billion total—but far below the pandemic peak.
October 8, 2024
·
4 min read
·
Greg Slabodkin
Policy
Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark
Zomedica Corp. announced it has secured the CE mark for its proprietary point-of-care TRUFORMA Bulk Acoustic Wave diagnostic platform.
June 25, 2024
·
6 min read
Gene editing
Patient Death Taints Otherwise Positive Data for Beam’s Sickle Cell Gene Therapy
BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, but a patient death underscores the need for less-toxic preconditioning treatments.
November 5, 2024
·
3 min read
·
Annalee Armstrong
BioCapital
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Today, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used to bring diagnosis to appropriately certified point-of-care settings for individuals at risk for hepatitis C.
June 27, 2024
·
5 min read
Deals
Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO
Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.
June 13, 2024
·
3 min read
1 of 25,804
Next
